New Evidence Shows Benefits...

Oral anticoagulants may reduce adverse clinical events in people with...

NAMI to FNIH: Grand...

Dr. Mark Mullen welcomes Dr. Christine Crawford, Chief Medical Officer at the National...

Planning a Wedding with...

Michelle Hammer and www.accessibleaisle.com worked together on this blog post. 10 tips to...
HomeVIDEOSSame Team. Same...

Same Team. Same 966 People. Two Opposite Answers on Sleep Apnea and Your Brain



In 2016, researchers followed 966 adults for fifteen years and found no link between sleep apnea and cognitive decline. Two years later, the same team, studying the same people, reported that severe apnea more than doubled the risk of dementia.

Both papers are correct. This video explains what changed between them, what the largest reviews actually show once you separate real sleep studies from medical records, and what happened when researchers treated apnea in a randomized trial and measured memory.

⏱️ CHAPTERS
0:00 The two studies that disagree
0:54 What sleep apnea actually is
2:11 The study that found nothing
3:17 The study that found the opposite
4:19 Why both are true
5:59 What a million people show
8:21 The study quoted out of context
9:51 What happened when they treated it
12:25 What the evidence supports
15:06 What we still don’t know
16:07 Closing

📚 SOURCES

1. Lutsey PL, Bengtson LG, Punjabi NM, et al. Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study. Sleep, 2016;39(2):309-316. n = 966, median follow-up 14.9 years.

2. Lutsey PL, Misialek JR, Mosley TH, et al. Sleep characteristics and risk of dementia and Alzheimer’s disease: The Atherosclerosis Risk in Communities Study. Alzheimer’s & Dementia, 2018;14(2):157-166. Severe OSA, all-cause dementia RR 2.35 (95% CI 1.06-5.18); Alzheimer’s 1.66 (1.03-2.68).

3. Guay-Gagnon M, Vat S, Forget MF, et al. Sleep apnea and the risk of dementia: A systematic review and meta-analysis. Journal of Sleep Research, 2022;31(5):e13589. 11 studies, 1,333,424 patients. Any neurocognitive disorder HR 1.43 (1.26-1.62). No significant association for vascular dementia.

4. Tian Q, Sun J, Li X, et al. Association between sleep apnoea and risk of cognitive impairment and Alzheimer’s disease: a meta-analysis of cohort-based studies. Sleep and Breathing, 2024;28(2):585-595. Pooled HR 1.52 (1.32-1.74); in polysomnography-diagnosed studies only, HR 1.32 (1.00-1.74).

5. Yaffe K, Laffan AM, Harrison SL, et al. Sleep disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA, 2011;306(6):613-619. 298 women, mean age 82.3. MCI/dementia 31.1% vs 44.8%; adjusted OR 1.85 (1.11-3.08).

6. Kushida CA, Nichols DA, Holmes TH, et al. Effects of Continuous Positive Airway Pressure on Neurocognitive Function in Obstructive Sleep Apnea Patients (APPLES). Sleep, 2012;35(12):1593-1602. Randomized, double-blind, sham-controlled. 1,105 randomized, 1,098 analyzed. Erratum: Sleep 2016;39(7):1483.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━

⚠️ This video is for general information only. It is not medical advice, and it is not a substitute for talking with your doctor. Never start, stop, or change any treatment based on a video. If you have concerns about your sleep or your memory, speak with a qualified health professional.

🎙️ The narration in this video is synthetic (text-to-speech). The research, the script, and the editorial choices are human.

Real science. No fear.

source

Continue reading

Does a psychedelic need an awake brain to have lasting effects? This mouse study offers a clue

A mouse study probing why psilocybin’s effects may depend on the brain’s starting state also tests a long-running question about whether being awake during the psychedelic...

New Evidence Shows Benefits of Anticoagulants in Atrial Fibrillation

Oral anticoagulants may reduce adverse clinical events in people with atrial fibrillation who have an intermediate risk of stroke.

NAMI to FNIH: Grand Rounds on Mental Health Innovation w/ Dr. Christine Crawford & Steve Hoffmann

Dr. Mark Mullen welcomes Dr. Christine Crawford, Chief Medical Officer at the National Alliance on Mental Illness (NAMI) and author of You Are Not Alone: For Parents and Caregivers, alongside Steve Hoffmann, Senior Vice President and Chief Preclinical Officer...